GlaxoSmithKline
Equities
Neil Woodford's top ten holdings in his Woodford Equity Income fund contain few surprises, with AstraZeneca, GlaxoSmithKline and British American Tobacco the three largest positions.
07 July 2014
•
1 min read
SRI
Neville White, socially responsible investment analyst at Ecclesiastical Investment Management, explains what investors should take away from recent high profile corporate governance scandals.
05 April 2012
•
Managed solutions
Multi-managers reveal the funds that helped them navigate their portfolios through a difficult 2011.
22 December 2011
•
6 min read
Equities
Low valuations and leaner companies mean now is a good time to increase equity holdings.
20 October 2011
•
